Inovio Pharmaceuticals, Inc. (INO)
1.18
+0.03
(+2.61%)
USD |
NASDAQ |
Apr 27, 13:11
Inovio Pharmaceuticals EPS Diluted (Quarterly) : 0.0546 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| ADMA Biologics, Inc. | 0.2025 |
| Vaxart, Inc. | 0.2289 |
| Agenus, Inc. | -0.301 |
| Capricor Therapeutics, Inc. | -0.6176 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.765M |
| Total Expenses (Quarterly) | -3.765M |
| Enterprise Value | 30.31M |
| Earnings Yield | -163.8% |
| Normalized Earnings Yield | -160.89 |